
An association between glycated hemoglobin (A1C) levels and fracture risk has been observed in the UK Biobank study.
While the detrimental effects of poor glycemic control in diabetes on various organ systems have been extensively investigated, its impact on skeletal health remains an area of ongoing research. Previous studies have established fracture risk as a complication of diabetes. However, understanding the complex relation between glycemic control, measured by glycated hemoglobin levels, and fracture risk in individuals with both Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) is crucial for implementing preventive measures and improving patient outcomes.
This study aimed to examine the relationship between glycemic control, BMD, and fracture risk in individuals with Type 1 and Type 2 diabetes. It comprised 452 131 individuals from the UK Biobank, with a mean age of 58 years. The UK Biobank is a prospective cohort study across 22 centers in the United Kingdom.
The results of the study showed that:
According to the authors: ‘Our study contributes to the growing body of evidence on the relationship between glycemic control, fractures, and bone health, highlighting the need for individualized management strategies in individuals with diabetes to optimize skeletal outcomes and reduce fracture risk. Furthermore, longitudinal studies with repeated measurements are needed to identify the key determinants of fracture risk in Type 2 diabetes’.
© 2026 Global Fragility Fracture Network | All Rights Reserved I Designed by Aaron Knight